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Themechanism ofthe neurologic complications associated with primary atypical pneumonia
is unknown. To examine the ability of Mycoplasmapneumoniae to enter the brain of experi-
mental animals, the organism was inoculated into adult and suckling mice by various routes.
After intranasal infection, M. pneumoniae was isolated from brains and lungs of both groups
of mice. After intracerebral inoculation, the high levels of the mycoplasma persisted for two
months or more in the brains of suckling mice. In addition, after intravenous infection, the
systemic spread ofinfection occurred in themicetreated with high doses ofcyclophosphamide.
Our results suggest that M. pneumoniaemay beable to reach the brain via blood and it may oc-
cur with relative ease in compromised hosts.
INTRODUCTION
Central nervous system complications of Mycoplasma pneumoniae infection in-
clude various symptoms such as encephalitis, meningitis, myelitis, polyradiculitis, or
acute psychosis. These neurologic complications are usually preceded by respiratory
symptoms although some patients give nohistory ofthe symptoms. The incidence of
central nervous system complications among M. pneumoniae infections was reported
to be about 0.1 percent. However, the incidence among hospitalized patients was as
high as 7 percent [1,2].
The overall incidence of current M. pneumoniae infections among patients wth
neurological syndromes was 5 percent, with a maximum of 10 percent during the
epidemic [3].
It is suggested that the complications may result from a direct invasion of M.
pneumoniae into the brain, a neurotoxin produced by the organism, cross-reacting
antibodies to antigen(s) shared by mycoplasma and brain, or from vascular
microthrombi with the organism [1]. However, the mechanism of the neurologic
disease associated with M. pneumoniae is not fully understood. The present study
was undertaken to examine the ability of M. pneumoniae to enter the brain of ex-
perimental animals. Adult and suckling mice were challenged with the organism by
various routes. In addition, cyclophosphamide-treated mice were infected with M.
pneumoniae to examine the susceptibility of compromised hosts to the infection.
MATERIALS AND METHODS
Animals
Specified pathogen-free ICR female mice, three to four weeks old, and suckling
mice of the same strain of both sexes were used in these experiments.
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Organism
M. pneumoniae strain 104166 was used as the inoculum for challenge of all ex-
perimental groups.
Challenge Procedure
Adult mice were infected with 25 ,/J of a PPLO broth suspension of M.
pneumoniae by intranasal instillation. Adult and suckling mice were exposed in a
desiccator with a nebulizer for 30 to 50 minutes to aerosol of the broth suspension.
Mice were also challenged with M. pneumoniae by the intracerebral route. Control
animals received sterile broth medium.
Cyclophosphamide (CY) Treatment
Adult mice were administered 260 mg CY per kg weight, intraperitoneally, once
daily for a total of four injections. The animals were then challenged intravenously
with M. pneumoniae.
Enumeration ofOrganisms
At appropriate intervals after infection, mice were killed to detect M. pneumoniae
present in lungs, brains, spleen, and blood. Each organ was homogenized in a glass
homogenizer containing 2 to 5 ml of PPLO broth, and blood (100 1l) was collected
in a test tube containing 2 ml of the broth. After centrifugation, the supernatant
fractions obtained from individual animals were plated on PPLO agar plates.
RESULTS
Recovery ofM. pneumoniaefrom Lungs ofAdult and Suckling Mice Infected by
Exposure to Aerosol
Young adult mice, 28 days old, and suckling mice, one to seven days old, were in-
fected with the mycoplasma by exposure to the aerosol. Nine ml ofthe broth culture
containing 4 x 10' CFU/ml was nebulized in a desiccator for 50 minutes. As shown
in Table 1, M. pneumoniae was not isolated from any of the lungs of 28-day-old
mice under this experimental condition. The susceptibility of one- to four-day-old
suckling mice to M. pneumoniae was much higher than that ofsix- to seven-day and
28-day-old mice, from the numbers of mycoplasmas isolated from lungs.
TABLE 1
Recovery of M. pneumoniae (CFU/Lung) from Mice Infected by Exposure to Aerosola
Days Days after birth
after
infection 28 7 6 4 3 2 1
0 2.6 x 103 3.5 x 103 1.3 x 104 1.5 x 104 3.6 x 104 2.2 x 104
7 0 2.1x103 5.6x 103 1.6x104 2.7x104 2.6x 104 4.8x 103
0 1.9 X 103 8.9 x 103 4.3 x 103 3.7 x 104 4.5 x 103 2.4 x 104
0 0 5.5x 102 1.2x104 4.5x102 3.1x 104 4.0x 103
14 0 0 3.5x 102 9.4x103 1.1X103 1.5x 102 8.9x 103
0 - 0 7.1x103 2.0x102 5.4x 103 1.4x 104
aNine ml ofthebroth culturecontaining 4 x 10' CFU/ml was nebulizedin adesiccator for 50minutes.
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Recovery ofM. pneumoniaefrom Lungs, Brains, and Blood After Aerosol or
Intranasal Instillation
Young adult mice, 28 days old, were infected with 106 CFU ofM. pneumoniae by
intranasal instillation under anesthesia. The mycoplasma was isolated from the
lungs and brains six days after the infection (Table 2). One-day-old suckling mice
were infected with the mycoplasma by exposure to the aerosol. At autopsy 13 days
later, the organisms were isolated from the lungs of all animals and from the brains
of two of four animals (Table 2). The numbers of organisms isolated from brains
were less than the numbers isolated from lungs. M. pneumoniae was not detected in
the blood of either the adult or suckling mice at any time of autopsy. The
mycoplasma was not isolated from any specimens of the control animals given
sterile broth medium throughout these experiments.
Recovery ofM. pneumoniaefrom Brains and Lungs After Intracerebral
Inoculation
Adult and suckling mice were infected with M. pneumoniae by intracerebral in-
oculation. In suckling mice, the numbers of mycoplasmas in the brains decreased in
the early stage after infection, then increased on day 20 (Exp. 1 in Table 3) and the
TABLE 2
Recovery of M. pneumoniae from Mice
Adult micea Suckling miceb
Days Lung Brain Lung Brain
post-infection (CFU/organ) (CFU/organ) (CFU/organ) (CFU/organ)
1.8 x 102 3.0 x 10 2.3 x 104 0
1.7 x 102 7.0 x 10 1.8 x 104 0 6 1.3 x 102 9.3 x 102 1.2 x 104 0
7.0 x 10 4.0 x 10 2.0 x 103 0
7.0 x 10 0 6.0 x 104 0
1.0 x 10 0 2.7 x 104 2.0 x 10
13 0 0 1.1 x 104 5.0 x 102
o 0 3.1 x 103 0
4.0 x 10 0 2.8 x 102 0
0 6.0 x 10 2.1 x 102 0 21 0 7.0 x 10 5.0 x 10 0
0 0 2.0x 10 0
o o
29 0 0 NDC ND o o
o o
o o
43 0 0 ND ND
o o
o o
aInfected intranasally with 106 CFU
bInfected by nebulization-Five ml of the broth culture containing 3.9 x 10' CFU/ml was nebulized
in a desiccator for 30 minutes.
cND, Not done
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TABLE 3
Recovery of M. pneumoniae from Three-Week-Old and One-Day-Old Mice
Infected by Intracerebral Inoculation
Mycoplasma recovery from brain (CFU/organ)
1-day-old mice
Time 3-week-old
post-infection micea Exp. 1a Exp. 2b
1.0 x 106 1.4 x 106
30 minutes 9.8 x 105 1.3 x 106 NDc
7.0 x 10s 1.2 x 106
5.3 x 105
3 days ND 0 ND
0
7.9 x 103 2.3 x 104
6 days 0 3.0 x 102 ND
0 2.0 x 102
5.2 x 103 3.7 x 104
13 days 0 3.0 x 103 ND
0 0
3.2 x 103 3.6 x 10'
20 days 5.0 x 102 1.8 x 104 ND
- 1.3 x 104
1.4 x 10' 2.1 x 104
26 days ND 4.5 x 104 2.4 x 104
7.4 x 103 0
6.6 x 103
35 days ND ND 2.2 x 104
1.3 x 104
7.2 x 103
50 days ND ND 4.5 x 102
0
1.2 x 103
70 days ND ND 3.4 x 103
aInoculated with 0.025 ml of PPLO broth containing 2 x 107 CFU
bInoculated with I x 106 CFU
cND, Not done
high levels of the organism persisted two months or more (Exp. 2 in Table 3). The
recovery from adult mice which had been inoculated with the same number ofmyco-
plasmas was lower than that from suckling mice. On the other hand, the organism
was not isolated from any lung of either the suckling or adult mice.
Treatment with Cyclophosphamide
Twenty-eight-day-old mice were subjected to treatment with CY to determine if
such treatment led to systemic infection. Severe leukopenia was caused by the treat-
ment. In such mice, M. pneumoniae was found not only in the lung but also in
brain, spleen, and blood after intravenous infection. Persistence of higher levels ofCENTRAL NERVOUS SYSTEM DISEASE
00t 00
x xx
N _~
0 0
el 00
N %O -
0 Q . . *
00 N > 0%
* * . x
X 000
N (O O
0
%O 0O O
\0000t
*x*x*x
_~0 >
0
O OO
< % 0 0
x
. .
x
000 I 0 rq _i _~ _ _:
0C)
X 0 0 0
x xoo
00
ON
0 a
0 0
000
X O a X
0 0
40 a C O
- in 0 0
O
e
Oi
0
0
xI
0
- o 0 0
0 0 0 0
0 000 100 0o
e0 0 0) N C- 0 en r-
0* *6
* .4
oo Co a _
CU
la
0 e0 0% 0
-4 -. - -
x x x x
0% ri - -
0
x 0 0 0
0
.o
4)
0
6.0
C)
0
4
E
.0
CU
0
0>
a.-
e4)
0.
CU
0
0
C)
C)
2C C
4)
U U
2 ._
2 a-C
CU
485
0
x
0
x
0 z
W.
z
z
z
- o
X
u
0 >~
U
O
0
U
U
0 O
W
0
U
W0
C:
CD
2
-
0
0
0 0
CU 00
0
U
0
0..
0
r-
e
CU
00
0
1-1
0 2
0
CU
S.
0
1-J
U)
x
.0
0
4)
CU
C)
C)
4)
0
-.C
CU
4)
4)
0^ > Q C) Z
.0 a Z
Ei
W)
0
U
0
0
0. F-
L-
4- A
r.486 OGATA AND KITAMOTO
the mycoplasma was noted in those organs during the three-day observation period.
On the other hand, in the infected mice which had not been treated with CY, the
mycoplasma was not found in the brain at four hours post-infection and disap-
peared rapidly from the lung, spleen, and blood (Table 4).
DISCUSSION
M. pneumoniae has been isolated from cerebrospinal fluid of patients with the
meningitis or meningoencephalitis associated with primary atypical pneumonia.
This fact suggests that M. pneumoniae can enter the central nervous system. We
reported at the Third IOM Congress that M. pneumoniae reached the brain of ex-
perimental animals, including adult hamsters and mice. Suckling animals as well as
adults were used in the present study.
M. pneumoniae was isolated from lungs and brains of the suckling mice infected
by exposure to the aerosol oftheorganism. The susceptibility ofsuckling mice to the
infection was much higher than that of adults, from the numbers of mycoplasmas
isolated from lungs.
To examine the possibility of reaching the brain via blood, mice were inoculated
intravenously with the mycoplasma. The systemic spread of infection occurred in
the mice treated with high doses ofcyclophosphamide. In addition, the high levels of
M. pneumoniae persisted for two months or more after the intracerebral inocula-
tion. This fact suggests that the organism can grow in the brain. However, there is
no evidence that the organism passes the blood-brain barrier after intravenous or in-
tranasal infection.
Finally, our results suggest thatM. pneumoniae may be able to reach the brain via
blood and it may occur with relative ease in compromised hosts. However, it seems
difficult for the mycoplasma to enter the parenchyma of brain of normal hosts
because the isolation rate and titers of the organism from brains were low in in-
travenously or intranasally infected animals throughout the present experiments. If
the injury of blood-brain barrier is produced by a cause such as metabolic disorder,
mixed infection, or unknown factor, M. pneumoniae will be able to enter the paren-
chyma of brain and to grow there.
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